Shijo, T., Sakurada, Y., Yoneyama, S., Kikushima, W., Sugiyama, A., Matsubara, M., . . . Kashiwagi, K. (2020). Association between Polygenic Risk Score and One-Year Outcomes Following As-Needed Aflibercept Therapy for Exudative Age-Related Macular Degeneration. Pharmaceuticals (Basel).
Chicago-стиль цитированияShijo, Taiyo, Yoichi Sakurada, Seigo Yoneyama, Wataru Kikushima, Atsushi Sugiyama, Mio Matsubara, Yoshiko Fukuda, Fumihiko Mabuchi, and Kenji Kashiwagi. "Association between Polygenic Risk Score and One-Year Outcomes Following As-Needed Aflibercept Therapy for Exudative Age-Related Macular Degeneration." Pharmaceuticals (Basel) 2020.
MLA-цитированиеShijo, Taiyo, et al. "Association between Polygenic Risk Score and One-Year Outcomes Following As-Needed Aflibercept Therapy for Exudative Age-Related Macular Degeneration." Pharmaceuticals (Basel) 2020.